WASHINGTON (Reuters) – Philip Morris International Inc should not be allowed to claim that its iQOS electronic tobacco device can reduce the risk of tobacco-related diseases compared with cigarettes, an advisory panel to the U.S. Food and Drug Administration said on Thursday.
Latest posts by Reuters News (see all)
- Dutch PM Rutte calls for further investigation into Khashoggi’s death - October 20, 2018
- UAE voices support for Saudi king statement on journalist’s death: WAM - October 20, 2018
- Saudi senior scholars praise king’s decisions on Khashoggi death - October 20, 2018